Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-18

Clinical Trial Update: Management of Persistent Epistaxis Using Floseal Hemostatic Matrix [NA]

View source ↗

Summary

Clinical trial update on using Floseal Hemostatic Matrix for managing persistent epistaxis with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLOSEAL Hemostatic Matrix (Hemostatic matrix)

Snippet

Sponsor: University of Alberta | Conditions: Epistaxis | NA | Status: COMPLETED | Results posted: 2023-01-18